2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Contributors
Farge, Dominique; Frere, Corinne; Connors, Jean M; Ay, Cihan; Khorana, Alok A; Munoz, Andres; Brenner, Benjamin; Kakkar, Ajay; Rafii, Hanadi; Solymoss, Susan; Brilhante, Dialina; Monreal, Manuel; Bounameaux, Henri; Pabinger, Ingrid; Douketis, James; International Initiative on Thrombosis and Cancer (ITAC) advisory panelPublished in
The Lancet Oncology, vol. 20, no. 10, p. e566-e581Publication date
2019Abstract
Keywords
- Anticoagulants/administration & dosage/therapeutic use
- Central Venous Catheters/adverse effects
- Factor Xa Inhibitors/therapeutic use
- Fondaparinux/therapeutic use
- Heparin, Low-Molecular-Weight/administration & dosage/therapeutic use
- Humans
- Neoplasms/complications/surgery
- Vena Cava Filters
- Venous Thromboembolism/drug therapy/etiology/prevention & control
- Vitamin K/antagonists & inhibitors
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
FARGE, Dominique et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. In: The Lancet Oncology, 2019, vol. 20, n° 10, p. e566–e581. doi: 10.1016/S1470-2045(19)30336-5
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:147133
- DOI : 10.1016/S1470-2045(19)30336-5
- PMID : 31492632
